GRK2 CLIA Kit
Kurzübersicht für GRK2 CLIA Kit (ABIN6213050)
Target
Alle GRK2 (ADRBK1) CLIA Kits anzeigenReaktivität
Nachweismethode
Methodentyp
Detektionsbereich
Applikation
Proben
-
-
Untere Nachweisgrenze
- 0.312 ng/mL
-
Verwendungszweck
- Human Adrenergic Receptor Beta Kinase 1 (ADRbK1) CLIA Kit is a Sandwich CLIA Kit for use with Serum, plasma, tissue homogenates and other biological fluids.
-
Analytische Methode
- Quantitative
-
Sensitivität
- < 0.125 ng/mL
-
-
-
-
Applikationshinweise
-
Stability: The stability of the kit is determined by the rate of activity loss. The loss rate is less than 5 % within the expiration date under appropriate storage conditions. To minimize performance fluctuations, operation procedures and lab conditions should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same user throughout.
Recommended dilutions: Optimal dilutions/concentrations should be determined by the end user.
Standard Form: Lyophilized
-
Plattentyp
- Pre-coated
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Upon receipt, store the kit according to the storage instruction in the kit's manual.
-
Haltbarkeit
- 6 months
-
-
- GRK2 (ADRBK1) (Adrenergic, Beta, Receptor Kinase 1 (ADRBK1))
-
Andere Bezeichnung
- ADRbK1
-
Pathways
- EGFR Signaling Pathway, Neurotrophin Signalübertragung, Regulation of G-Protein Coupled Receptor Protein Signaling, CXCR4-mediated Signaling Events, G-protein mediated Events, Interaction of EGFR with phospholipase C-gamma, Thromboxane A2 Receptor Signaling
Target Alle GRK2 (ADRBK1) CLIA Kits anzeigen
-